IRIS
BISCOTTI, TOMMASINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 655
EU - Europa 279
AS - Asia 99
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 655
UA - Ucraina 66
IT - Italia 61
SE - Svezia 39
IE - Irlanda 33
CN - Cina 32
DE - Germania 31
TR - Turchia 29
DK - Danimarca 25
SG - Singapore 22
FI - Finlandia 15
CI - Costa d'Avorio 14
KR - Corea 13
GB - Regno Unito 7
IN - India 3
EU - Europa 2
FR - Francia 2
Totale 1.049
Salva come PNG Salva come JPEG
Città #
Chandler 101
Fairfield 80
Jacksonville 68
Ashburn 52
Seattle 39
Wilmington 36
Houston 35
Dublin 33
Cambridge 32
New York 30
Woodbridge 30
Boardman 17
Centro 17
Abidjan 14
Lawrence 14
Princeton 14
San Mateo 14
Porto 11
Singapore 11
Ann Arbor 10
San Diego 9
Beijing 6
Cagliari 6
Chiaravalle 5
Guangzhou 5
Shanghai 4
Kilburn 3
Pune 3
Turin 3
Ancona 2
Des Moines 2
Helsinki 2
Wuhan 2
Arqua Petrarca 1
Jiaxing 1
London 1
Los Angeles 1
Porto San Giorgio 1
Quanzhou 1
Suzhou 1
Washington 1
Yiwu 1
Totale 719
Salva come PNG Salva come JPEG
Nome #
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 102
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 101
Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection 98
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 79
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 78
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 77
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 76
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 75
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 72
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. 67
The Pathology of Breast Cancer 67
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 66
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. 60
analisi immunoistochimica e molecolare (CISH/FISH) dei fattori predittivi di risposta alla terapia irinotecan-cetuximab nel carcinoma del colon-retto in stadio avanzato 60
Totale 1.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 1 1 13 0 13 1 13 0 13 9 0 25
2020/2021313 15 33 26 1 65 40 20 18 17 40 26 12
2021/2022113 6 35 2 0 0 6 8 5 4 16 12 19
2022/2023229 15 38 14 19 30 26 0 7 62 3 12 3
2023/2024145 19 3 7 17 14 49 5 10 2 3 2 14
2024/202542 42 0 0 0 0 0 0 0 0 0 0 0
Totale 1.078